Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 34110923

FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Oct 10
First author
Schmitt-Hoffner F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Schmitt-Hoffner F
      type
      Author
    2. name
      van Rijn S
      type
      Author
    3. name
      Toprak UH
      type
      Author
    4. name
      Mauermann M
      type
      Author
    5. name
      Rosemann F
      type
      Author
    6. name
      Heit-Mondrzyk A
      type
      Author
    7. name
      Hübner JM
      type
      Author
    8. name
      Camgöz A
      type
      Author
    9. name
      Hartlieb S
      type
      Author
    10. name
      Pfister SM
      type
      Author
    11. name
      Henrich KO
      type
      Author
    12. name
      Westermann F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Schmitt-Hoffner F
      type
      Author
    2. name
      van Rijn S
      type
      Author
    3. name
      Toprak UH
      type
      Author
    4. name
      Mauermann M
      type
      Author
    5. name
      Rosemann F
      type
      Author
    6. name
      Heit-Mondrzyk A
      type
      Author
    7. name
      Hübner JM
      type
      Author
    8. name
      Camgöz A
      type
      Author
    9. name
      Hartlieb S
      type
      Author
    10. name
      Pfister SM
      type
      Author
    11. name
      Henrich KO
      type
      Author
    12. name
      Westermann F
      type
      Author
    bibliography ids
    1. nci-bib-48881d01fa4efddad9998d43
    book metadata
    content sha256
    47419fb2ed0a0558283bf061e7cbb036e9a260ecd263e7151535dc4c8ec5a327
    document type
    citation
    dois
    1. 10.1200/JCO.20.02540
    electronic publication date
    display
    2021 Jun 10
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34110923
    immutable id
    pubmed:34110923@47419fb2ed0a0558283bf061e7cbb036e9a260ecd263e7151535dc4c8ec5a327
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    29
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3217-3228
    volume
    39
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34110923
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      6bb60dc009f6eb72bafb474cd2379bb052eabddf9e1d2418d9b51cf80a3a86f5
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Oct 10
      precision
      day
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34110923/
      title
      FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome.

      Preserved source evidence · Independent clinical review pending · Not medical advice